Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M274Revenue $M29.0Net Margin (%)-159.9Z-Score-0.8
Enterprise Value $M247EPS $-21.5Operating Margin %-152.2F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-159.8Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio4.4Cash flow > EarningsN
Price/Sales5.65-y EBITDA Growth Rate %0Current Ratio5.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-60.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-95.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M23.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with TNDM

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

TNDM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


TNDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sheridan John FEVP & CHIEF OPERATING OFFICER 2015-02-02Sell2,000$12.06-1view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2015-01-02Sell2,000$12.75-6.35view
Allen DickDirector 2014-12-12Buy10,000$11.95-0.08view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-12-01Sell2,000$13.55-11.88view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-11-03Sell2,000$16-25.38view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-10-01Sell2,000$13.07-8.65view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-09-02Sell2,000$13.99-14.65view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-08-01Sell2,000$15.04-20.61view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-07-01Sell2,000$16.42-27.28view
Sheridan John FEVP & CHIEF OPERATING OFFICER 2014-06-18Sell2,000$16.75-28.72view

Press Releases about TNDM :

    Quarterly/Annual Reports about TNDM:

    News about TNDM:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Tandem Diabetes reports 4Q loss Feb 24 2015
    Tandem Diabetes reports 4Q loss Feb 24 2015
    Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results Feb 24 2015
    Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock Feb 24 2015
    Tandem Diabetes Care Inc Earnings Call scheduled for 4:30 pm ET today Feb 24 2015
    Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock Feb 24 2015
    4:09 pm Tandem Diabetes Care beats by $0.03, beats on revs; guides FY15 revs below consensus Feb 24 2015
    TANDEM DIABETES CARE INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 24 2015
    Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results Feb 24 2015
    Q4 2014 Tandem Diabetes Care Inc Earnings Release - After Market Close Feb 24 2015
    Tandem Diabetes Care Launches t:simulator™ Demonstration App Feb 20 2015
    Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2014 Earnings Press Release and... Feb 10 2015
    3 Med-Instrument Stocks Poised to Gain this Earnings Season - Earnings ESP Feb 09 2015
    Free Lunch grinds to a close Feb 03 2015
    TANDEM DIABETES CARE INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 23 2015
    Volatile market stymies bargain stock basket Jan 14 2015
    Tandem Diabetes Care Announces FDA Clearance of the t:flex™ Insulin Pump Jan 12 2015
    TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 12 2015
    Tandem Diabetes Care Announces FDA Clearance of the t:flex™ Insulin Pump Jan 12 2015
    Bargain stocks on the rise already Dec 24 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK